# Strategy Live Delta

Rolling log for strategy and plan corrections between major strategy documents.

## 2026-05-08 16:36 MSK
### Artifact Delta
- Re-read the latest controlling artifacts for a dedicated strategy refresh:
  - `docs/PROJECT_PULSE_LOG.md`
  - `docs/KNOWLEDGE_SYNC_HUB.md`
  - `docs/AGENT_CONTEXT_HUB.md`
  - `docs/WELLNESS_DIALOGUE_QA_20260506.md`
  - `ops/reports/quality_report_20260506T080435Z.md`
  - `WellnessBot/data/submissions/20260501T162705Z_1084557944.json`
  - `WellnessBot/data/submissions/20260505T131604Z_1084557944.json`
  - `WellnessBot/data/submissions/20260427T173913Z_1084557944.json`
  - `WellnessBot/data/submissions/20260425T214914Z_1084557944.json`
  - `WellnessBot/data/submissions/20260425T212847Z_1084557944.json`
  - `WellnessBot/data/product_governance.json`
  - `mini-app/index.html`
  - `bot.stderr.log`
- No new shipping proof landed after the earlier `2026-05-08 04:38 MSK` refresh:
  - repo head is still `fe7a358` (`feat: guide manual lab entry`)
  - the last product-shaping code commits are still `fe7a358` and `176ac82`
  - governance/task pressure is unchanged:
    - `127` experiments
    - `4` duplicate title groups
    - largest duplicate group `x8`
    - `29` `docs/tasks/HERMES-20260505-*` files
  - the governing delivered `week` case still shows:
    - `intake_status = delivered_to_client`
    - `judge_verdict = needs_revision`
    - `lab_quality_check.status = missing`
    - `requires_lab_resubmission = true`
  - the fresh paid `premium` case is still parallel rather than normalized:
    - `20260505T131604Z_1084557944`
    - `manual_payment_confirmed`
    - `intake_status = review_priority_quality_and_market`
    - `judge_verdict = pass_with_minor_edits`
  - runtime evidence is unchanged:
    - active path still logs `proxy=http://127.0.0.1:12334`
    - local `GET /health` still last shows `404` at `2026-05-08 00:35:06 +0300`
- The new evidence in this refresh is therefore not a product-direction change.
- The new evidence is that the project is now at risk of repeating a strategy/planning loop on top of an unchanged artifact set.

### Product Direction Delta
- Product direction does not need expansion.
- Product direction now needs enforcement:
  - one canonical reviewed Telegram thread per user
  - `week` as the paid entry rail
  - `premium` only as a same-case continuation from that thread
- The team should stop treating `premium` demand, manual-lab UX landing, or mini-app presence as permission to run parallel commercial narratives.

### Value Proposition Delta
- The strongest live value proposition is still:
  - `one Telegram thread that keeps moving even when labs arrive as PDF, photo, or structured manual text, with human review before any client-facing conclusion`
- The current credibility ceiling is not a missing feature.
- The current credibility ceiling is:
  - unresolved review-safe delivery
  - unresolved same-user case ownership
  - unresolved mini-app truth drift

### Monetization Delta
- Monetization posture stays:
  - `week` -> `3900 RUB`
  - `premium` -> `6900 RUB`
  - `vip` -> `14900 RUB`
  - manual concierge payment only
- Monetization demand is now validated twice on the same user stack:
  - one paid `week`
  - one paid `premium`
- The monetization path is still blocked by execution truth, not by pricing, checkout, or packaging.
- Commercial rule for the next cycle:
  - no second active paid storyline
  - `premium` must be explicitly merged into the canonical case or frozen

### Operating Delta
- The next 12h should produce proof, not more strategic interpretation of the same facts.
- The only high-leverage order remains:
  1. hard delivery gate
  2. canonical-case classification across the five same-user branches
  3. mini-app result-surface neutralization
  4. manual-lab fallback verification plus tests
  5. proxy / health-check decision
  6. only then benchmark or premium-conversion refinement
- Until one of those lands, new strategy notes, readiness drafts, or task packets are execution-negative.

### Safety Delta
- Legal and safety posture does not change:
  - no diagnosis framing
  - no treatment framing
  - urgent-care routing stays mandatory
  - human review stays mandatory
  - typed lab text remains fallback input, not confirmed medical fact
- Strategy refresh itself is now a safety issue if it delays resolution of the live delivery defect and the unsafe mini-app surface.

### Inefficiency Loop Delta
- Repeated low-impact loop:
  - rereading the same May 8 artifact set and producing another status artifact without landing a delivery, branch, surface, file-fallback, or runtime fix
- Repeated low-impact loop:
  - continuing HERMES task-packet / readiness-draft generation while `127` experiments and `29` same-day task files already exist
- Repeated low-impact loop:
  - debating premium growth while the same user still carries one unresolved delivered `week` plus a fresh paid `premium` branch
- Repeated low-impact loop:
  - quality-discussion motion before delivery truth, mini-app truth, and runtime truth are repaired

### Higher-Impact Replacement Action
- Replace net-new planning churn for the next 12h with one bounded canonical-case collapse packet:
  1. enforce the delivery gate and override audit trail
  2. classify all five same-user branches as `canonical / merge-into-canonical / evidence-only / parked / archive`
  3. replace the hardcoded mini-app result surface with a safe placeholder
  4. run manual-lab fallback verification on PDF, readable photo, poor photo, and structured manual text, with tests
  5. decide whether proxy is required and wire or document the real health check
  6. write the next strategy note only after at least one of the above lands

### Must-Hold Rules
- Keep Telegram as the only live operating channel.
- Keep manual concierge as the official pilot payment mode.
- Keep official pilot prices locked at `3900 / 6900 / 14900 RUB` unless a strategy doc explicitly changes them.
- Keep `week` as the validated paid entry rail.
- Keep `premium` as the flagship offer only as a same-case continuation, not as a second active storyline.
- Keep exactly one canonical paid path per Telegram user.
- Keep human review mandatory before delivery.
- Keep no-diagnosis, no-treatment, urgent-care, and lab-quality rules explicit.
- Do not let new strategy refreshes, readiness drafts, or task packets outrun direct P0 fixes on delivery truth, case ownership, mini-app truth, file-fallback proof, or runtime health.

## 2026-05-08 04:38 MSK
### Artifact Delta
- Re-read the current source-of-truth artifacts before refreshing strategy:
  - `docs/PROJECT_PULSE_LOG.md`
  - `docs/KNOWLEDGE_SYNC_HUB.md`
  - `docs/AGENT_CONTEXT_HUB.md`
  - `docs/WELLNESS_DIALOGUE_QA_20260506.md`
  - `ops/reports/quality_report_20260506T080435Z.md`
  - `docs/GLOBAL_EXECUTION_MASTER_PLAN_20260506.md`
  - `docs/OCR_PREFLIGHT_STATUS_20260506.md`
  - `docs/BIOMARKER_EXTRACTION_DECISION_20260506.md`
  - `WellnessBot/data/submissions/20260501T162705Z_1084557944.json`
  - `WellnessBot/data/drafts/20260501T162705Z_1084557944.review.json`
  - `WellnessBot/data/submissions/20260505T131604Z_1084557944.json`
  - `WellnessBot/data/product_governance.json`
  - `WellnessBot/main.py`
  - `WellnessBot/lab_ocr.py`
  - `WellnessBot/texts.py`
  - `mini-app/index.html`
  - `bot.stderr.log`
- New controlling evidence since the `2026-05-06 09:31 MSK` refresh:
  - a second paid path now exists for the same Telegram user:
    - `20260505T131604Z_1084557944`
    - offer `premium`
    - `manual_payment_confirmed`
    - `intake_status = review_priority_quality_and_market`
    - `judge_verdict = pass_with_minor_edits`
  - this materially worsens canonical-path drift:
    - one user now spans one delivered `week`, one fresh paid `premium`, one stale `week` placeholder, and two older `premium` branches
    - monetization demand is stronger, but commercial truth is less coherent
  - file fallback improved in code on `2026-05-06` and `2026-05-07`:
    - commit `176ac82` adds clearer resubmission guidance plus a rewrite prompt for malformed manual lab text
    - commit `fe7a358` adds a manual-entry button in the labs flow, stronger nurture copy, and explicit structured examples for typed biomarker input
    - this is a real product affordance, not just a strategy idea
    - it is still not proven end-to-end on a reviewed live case
  - the governing `week` case remains the P0 truth failure:
    - `intake_status = delivered_to_client`
    - attached review still says `needs_revision`
    - no explicit override note is recorded
    - lab state is now clearly unresolved rather than merely inconsistent:
      - `lab_quality_check.status = missing`
      - `requires_lab_resubmission = true`
      - client follow-up keeps arriving anyway, including `2026-05-07T20:46:50Z`
  - the mini-app still drifts from policy:
    - `mini-app/index.html` still hardcodes `Витамин D3: 5000 МЕ + K2`
    - still hardcodes `LCHF`
    - still uses a hardcoded `Premium Wellness-Досье` result screen
  - current quality truth is now `2026-05-06`, not `2026-05-01`:
    - router/model split held at `11/20` deterministic and `9/20` model-path
    - clarifying-question coverage slipped to `6/9`
    - unsupported name hallucination appears twice
    - `5/9` model-path replies are longer than `2000` characters
    - emergency templates are still duplicated across materially different risk classes
  - runtime evidence updated again:
    - bot restarted cleanly on `2026-05-07 23:46:49-23:46:50 MSK`
    - active path still logs `proxy=http://127.0.0.1:12334`
    - local `GET /health` at `2026-05-08 00:35:06 +0300` returned `404`
    - runtime is up again, but health signaling and no-proxy proof are still absent
  - governance/task-loop pressure is unchanged and still negative:
    - `127` experiments
    - `4` duplicate title groups
    - largest duplicate group `x8`
    - `29` `docs/tasks/HERMES-20260505-*` files

### Product Direction Delta
- Core direction still holds:
  - Telegram-first only
  - manual concierge payment remains the official pilot mode
  - `week` remains the validated paid entry rail
  - `premium` remains the flagship offer
  - `vip` remains parked
- The important correction today is structural:
  - the product is not `week` plus a separate premium branch for the same user
  - the product is `one reviewed Telegram thread that can continue with PDF, photo, or structured manual lab text`
  - premium must be a same-case upgrade from that thread, not a second active commercial storyline
- Therefore the immediate product story becomes:
  - `Telegram-first clarity -> review-safe week delivery -> same-case follow-up with file or manual labs -> one premium upgrade from the same canonical case`
  - not `spawn another paid case when follow-up evidence arrives`
  - not `mini-app result proof`
  - not `manual-lab UX shipped therefore file reliability solved`

### Value Proposition Delta
- The clearest current value proposition is now:
  - `one Telegram thread that still moves forward when lab files are imperfect, because the client can send PDF, photo, or structured manual biomarkers and still get a reviewed next-step map`
- This is stronger than the prior OCR-auth story because it matches actual landed UX.
- The trust gap is also sharper:
  - the same user already paid twice while the original delivered case still fails review
  - manual lab entry exists, but there is still no end-to-end proof artifact showing safe reviewed behavior from typed labs
  - the mini-app still shows a more autonomous medical-style product than the reviewed backend

### Monetization Delta
- Official monetization posture remains unchanged:
  - `week` -> `3900 RUB`
  - `premium` -> `6900 RUB`
  - `vip` -> `14900 RUB`
  - payment mode stays manual concierge
- The monetization correction today is sequence and packaging:
  - the new paid `premium` case proves willingness to pay beyond `week`
  - but it does not justify parallel same-user case creation or faster scaling
  - the actual monetization unlock is:
    - same-case premium conversion discipline
    - reviewed follow-up evidence
    - safe manual-lab fallback when files are weak
- So the next revenue move is not a new package or payment rail.
- The next revenue move is:
  - merge or explicitly relate `20260505T131604Z_1084557944` to the canonical `week` follow-up story
  - then prove one clean premium-upgrade flow from the same case

### Operating Delta
- Active blocker order now sharpens to:
  - delivery-gate integrity
  - same-user commercial stack normalization including the new `20260505` premium case
  - manual-lab fallback proof on a real reviewed flow
  - mini-app result-surface truth
  - proxy dependency and health-check truth
  - model-path discipline
  - connector recovery
- The real operational gain is narrow but useful:
  - manual biomarker entry is now a coded fallback path
  - the team can stop pretending that only clean OCR can move a case forward
- The real operational limit is still explicit:
  - this path has not yet been proven end-to-end with reviewed output, tests around the new callbacks, or a benchmarked live case artifact

### Safety Delta
- Legal and safety posture remains unchanged:
  - no diagnosis framing
  - no treatment framing
  - urgent-care routing remains mandatory
  - human review remains mandatory before delivery
  - unclear labs cannot become product facts
- The new safety clarification is specific:
  - manual biomarker text is acceptable only when structure is clear enough to avoid value/name/unit confusion
  - typed labs are a fallback path, not permission to infer or fill gaps
  - a second paid case must not be used to outrun the unresolved safety state of the original delivered case

### Inefficiency Loop Delta
- Repeated low-impact loop:
  - creating or debating more premium experiments while the same user already has parallel paid paths
- Repeated low-impact loop:
  - treating landed manual-lab UX as if end-to-end file reliability were already proven
- Repeated low-impact loop:
  - rerunning quality narratives off the `2026-05-01` benchmark while `2026-05-06` QA already shows the next real discipline problems
- Repeated low-impact loop:
  - status and planning motion while the mini-app still ships hardcoded result content and the proxy-backed runtime still lacks a clean health proof

### Higher-Impact Replacement Action
- Run one canonical follow-up conversion hardening sweep, in this order:
  1. add or verify the hard delivery guard so unresolved review verdicts cannot move to `delivered_to_client` without an explicit override note
  2. normalize `20260501T162705Z_1084557944` so follow-up state, lab state, and delivery truth match
  3. classify the same-user stack into `canonical / merge-into-canonical / evidence-only / parked / archive`, with `20260505T131604Z_1084557944` explicitly handled rather than left floating
  4. prove the manual-text fallback on one real reviewed flow and add tests around the new callbacks / rewrite prompts
  5. replace the hardcoded mini-app result surface with a safe placeholder
  6. prove whether proxy is required and add a real health endpoint or documented equivalent
  7. only then shape one premium-upgrade brief from the canonical same-case follow-up

### Must-Hold Rules
- Keep Telegram as the only live operating channel.
- Keep manual concierge as the official pilot payment mode.
- Keep official pilot prices locked at `3900 / 6900 / 14900 RUB` unless a strategy doc explicitly changes them.
- Keep `week` as the validated paid entry rail.
- Keep `premium` as the flagship offer, but express it as a same-case upgrade from fresh follow-up evidence rather than as a parallel branch.
- Keep exactly one canonical paid path per Telegram user.
- Keep human review mandatory before delivery.
- Keep no-diagnosis, no-treatment, urgent-care, and lab-quality rules explicit.
- Do not treat manual-lab UX landing as proof that file/lab reliability is solved.
- Do not let the same user carry both an unresolved delivered `week` truth defect and a separate active premium proof story.
- Do not let the mini-app show hardcoded supplement protocols or medical-style result copy as if it were reviewed truth.
- Do not let governance, task swarms, or premium experiment churn outrun delivery truth, canonical-case truth, manual-fallback proof, and runtime proof.

## 2026-05-06 09:31 MSK
### Artifact Delta
- Re-read the current source-of-truth artifacts before refreshing strategy:
  - `docs/PROJECT_PULSE_LOG.md`
  - `docs/KNOWLEDGE_SYNC_HUB.md`
  - `docs/AGENT_CONTEXT_HUB.md`
  - `docs/GLOBAL_EXECUTION_MASTER_PLAN_20260506.md`
  - `docs/OCR_PREFLIGHT_STATUS_20260506.md`
  - `docs/BIOMARKER_EXTRACTION_DECISION_20260506.md`
  - `docs/CONTROLLED_PILOT_STRATEGY_V2_20260505.md`
  - `docs/DOMAIN_SITE_MINIAPP_STRATEGY_20260505.md`
  - `docs/MODEL_CONTEXT_START_HERE_20260505.md`
  - `docs/HERMES_PROJECT_WORKER_PROTOCOL_20260505.md`
  - `WellnessBot/data/submissions/20260501T162705Z_1084557944.json`
  - `WellnessBot/data/drafts/20260501T162705Z_1084557944.review.json`
  - `WellnessBot/data/product_governance.json`
  - `mini-app/index.html`
  - `ops/yandex_ocr_preflight.py`
- New controlling evidence since the `2026-05-05 21:34 MSK` refresh:
  - latest repo head is now `4cd1396` (`docs: add global execution plan and ocr preflight`)
  - OCR auth is no longer the leading file/lab blocker:
    - `docs/OCR_PREFLIGHT_STATUS_20260506.md` records a pre-IAM `401`
    - the same preflight now returns `auth_path_ok` with `400` on a synthetic `1x1 PNG`, which is acceptable for auth validation
    - the next file/lab risk is now functional verification on real PDF/photo inputs plus client fallback behavior
  - deterministic biomarker extraction was safely widened, but the policy line sharpened:
    - standard aliases were expanded in `WellnessBot/lab_ocr.py`
    - DeepSeek-based extraction is explicitly not accepted as a fact source without confidence, merge, and audit rules
  - the global execution plan keeps the commercial shape unchanged:
    - controlled concierge pilot
    - Telegram-first
    - manual concierge payment
    - no public launch yet
  - the governing `week` case remains the P0 product-truth failure:
    - `intake_status = delivered_to_client`
    - `judge_verdict = needs_revision`
    - `requires_lab_resubmission = true`
    - no explicit manual override note is recorded
  - the mini-app still visibly drifts from policy:
    - off-policy `от 2 990 ₽`
    - hardcoded supplement-style result content remains present
  - governance/task pressure remains execution-negative:
    - `127` experiments remain accumulated in `WellnessBot/data/product_governance.json`
    - `29` same-day `docs/tasks/HERMES-20260505-*` files still exist

### Product Direction Delta
- Core direction still holds:
  - Telegram-first only
  - manual concierge payment remains the official pilot mode
  - `week` remains the validated paid entry rail
  - `premium` remains the flagship offer
  - `vip` remains parked
- The important correction today is operational:
  - OCR auth recovery is useful
  - but it does not outrank delivery truth, canonical path control, or mini-app truth
  - the file/lab track should now be described as `auth path cleared, functional reliability not yet proven`
- Therefore the immediate product story stays:
  - `Telegram-first clarity -> review-cleared delivery -> same-case follow-up -> premium upgrade from fresh evidence`
  - with safe file fallback when OCR is weak
  - not `mini-app proof`
  - not `AI extraction expansion as launch proof`
  - not `Hermes task volume as execution proof`

### Value Proposition Delta
- The clearest current value proposition becomes slightly sharper:
  - `one Telegram thread that turns symptom and lab chaos into a reviewed next-step map, even when file quality is imperfect`
- The trust gap is also clearer:
  - OCR auth is fixed, but real file handling still needs proof on live PDF/photo cases
  - the same delivered `week` case still fails its own review gate
  - the mini-app still shows a cheaper and less safe product than the reviewed backend
- The next trust win is therefore:
  - fix delivery truth first
  - verify real file fallback second
  - keep all new evidence on the same canonical case third
  - neutralize the mini-app drift fourth

### Monetization Delta
- Official monetization posture remains unchanged:
  - `week` -> `3900 RUB`
  - `premium` -> `6900 RUB`
  - `vip` -> `14900 RUB`
  - payment mode stays manual concierge
- The monetization correction today is sequence:
  - OCR auth repair means the team no longer needs to pause the offer story because of a known broken auth path
  - but it still cannot scale the premium promise until real file tests and fallback language are proven
  - the actual revenue blocker remains delivery trust, not payment automation or a new surface

### Operating Delta
- Runtime/storage truth remains improved relative to early May:
  - runtime mismatch is still cleared
  - bot runtime is still described as back up, but not yet proven resilient
- File/lab operations improved one layer:
  - auth failure moved from active blocker to resolved environment issue
  - functional verification on real files is still pending and must stay explicit
- Active blocker order now sharpens to:
  - delivery-gate integrity
  - governing-case lab-state normalization
  - canonical same-user path retirement
  - mini-app copy and pricing coherence
  - polling transport proof
  - real OCR/file fallback verification
  - connector recovery

### Safety Delta
- Legal and safety posture remains unchanged:
  - no diagnosis framing
  - no treatment framing
  - urgent-care routing remains mandatory
  - human review remains mandatory before delivery
  - unreadable or uncertain labs cannot become product facts
- The new safety clarification is specific:
  - expanded deterministic marker aliases are acceptable
  - AI-assisted biomarker extraction is not allowed to invent or promote unverified values into client truth
  - OCR auth recovery does not justify stronger medical claims on any surface

### Inefficiency Loop Delta
- Repeated low-impact loop:
  - generating Hermes task packets and strategy sidecars while the same P0 delivery and state defects stay open
- Repeated low-impact loop:
  - debating broader AI biomarker extraction before the real PDF/photo fallback path is verified
- Repeated low-impact loop:
  - treating OCR auth recovery as if the full file/lab reliability problem were solved
- Repeated low-impact loop:
  - letting mini-app and architecture narratives compete with Telegram-first pilot truth

### Higher-Impact Replacement Action
- Run one truth-and-file-hardening sweep, in this order:
  1. add or enforce the hard delivery guard so unresolved review verdicts cannot move to `delivered_to_client` without an explicit override note
  2. normalize the governing `week` case so review state and lab-state flags match the actual follow-up truth
  3. classify the same-user stack into `canonical / archive / parked / evidence-only`
  4. replace the mini-app `2990` price drift and hardcoded result demo with a safe placeholder aligned to Telegram-first reviewed truth
  5. prove the current polling path with an explicit proxy-required or no-proxy determination
  6. run real file-lab verification on PDF, good photo, poor photo, and manual biomarker text so OCR fallback becomes a measured behavior instead of a plan
  7. keep DeepSeek extraction in candidate-only mode until confidence/merge/audit rules exist

### Must-Hold Rules
- Keep Telegram as the only live operating channel.
- Keep manual concierge as the official pilot payment mode.
- Keep official pilot prices locked at `3900 / 6900 / 14900 RUB` unless a strategy doc explicitly changes them.
- Keep `week` as the validated paid entry rail.
- Keep `premium` as the flagship offer, but prove it from fresh post-`week` evidence rather than stale same-user branches.
- Keep exactly one canonical paid path per Telegram user.
- Keep human review mandatory before delivery.
- Keep no-diagnosis, no-treatment, urgent-care, and lab-quality rules explicit.
- Do not treat OCR auth recovery alone as proof that file/lab reliability is solved.
- Do not treat AI-assisted biomarker extraction as a fact source without confidence, merge, and audit controls.
- Do not let the mini-app show off-policy pricing, hardcoded supplement protocols, or hardcoded biomarker conclusions as if they were live truth.
- Do not let governance, task-swarm growth, or architecture sidecars outrun delivery truth, canonical path truth, transport proof, and real file fallback verification.

## 2026-05-05 21:34 MSK
### Artifact Delta
- Re-read the current source-of-truth artifacts before refreshing strategy:
  - `docs/PROJECT_PULSE_LOG.md`
  - `docs/KNOWLEDGE_SYNC_HUB.md`
  - `docs/AGENT_CONTEXT_HUB.md`
  - `docs/WELLNESS_DIALOGUE_QA_20260501.md`
  - `ops/reports/quality_report_20260501T080509Z.md`
  - `WellnessBot/data/runtime_state.json`
  - `WellnessBot/data/submissions/20260501T162705Z_1084557944.json`
  - `WellnessBot/data/drafts/20260501T162705Z_1084557944.review.json`
  - `WellnessBot/data/submissions/20260427T173913Z_1084557944.json`
  - `WellnessBot/data/submissions/20260425T212847Z_1084557944.json`
  - `WellnessBot/data/submissions/20260425T214914Z_1084557944.json`
  - `WellnessBot/data/product_governance.json`
  - `mini-app/index.html`
  - `landing/index.html`
  - `bot.stderr.log`
- New controlling evidence since the `2026-05-05 21:30 MSK` refresh:
  - the bot remains up on the `2026-05-05 17:15:53-17:16:00 MSK` restart path
  - the same-day operational question is no longer `is the bot down?`; it is `can the currently running path be trusted without a proxy failure relapse?`
  - no newer benchmark artifact exists than `ops/reports/quality_report_20260501T080509Z.md`
  - the delivered `week` case still shows `intake_status = delivered_to_client` while its attached review still says `needs_revision`, and there is still no explicit override note
  - the same `week` case now also contains a new state conflict after same-day follow-up:
    - `lab_quality_check.status = ok`
    - `requires_lab_resubmission = true`
  - the same user still also carries:
    - stale `week` placeholder `20260427T173913Z_1084557944` at `consent_pending`
    - paid `premium` branch `20260425T212847Z_1084557944` with `must_rewrite_with_high_caution`
    - paid `premium` branch `20260425T214914Z_1084557944` with `lab_quality_check.requires_resubmission = true`
  - the mini-app still advertises off-policy `2990` pricing and still renders hardcoded ferritin / vitamin D / cortisol claims plus supplement-dose and `LCHF` result output
  - latest local commit is `2cecec2`, but the fresh repo motion is still docs/hermes-heavy rather than pilot-defect-closing
  - Notion and GitHub connector startups currently fail with `MCP startup failed: timed out awaiting tools/list after 30s`
  - Google Drive upload/share tools are still not exposed in the session

### Product Direction Delta
- Core direction still holds:
  - Telegram-first only
  - manual concierge payment remains the official pilot mode
  - `week` remains the validated paid entry rail
  - `premium` remains the flagship offer
  - `vip` remains parked
- The important same-day correction is operational:
  - the next strategy win is not `restart the bot`
  - the bot is already back
  - the next strategy win is `turn the current proxy-backed restart into a transport path that is explicitly trusted or explicitly replaced`
- Therefore the immediate product story stays:
  - `Telegram-first clarity -> review-cleared delivery -> normalized follow-up truth -> premium upgrade from fresh evidence`
  - not `mini-app proof`
  - not `stale premium proof`
  - not `docs moving ahead while the governing case is internally contradictory`

### Operating Delta
- Runtime/storage truth remains better than the April orphan blocker set:
  - runtime state is empty
  - disk headroom is acceptable
  - the bot is currently running again
- But the active blocker order now sharpens to:
  - delivery-gate integrity
  - governing-case lab-state normalization
  - canonical same-user path retirement
  - mini-app copy / price coherence
  - proxy or no-proxy transport proof
  - connector recovery for Notion/GitHub/Google Drive
  - model-path discipline
- Current same-user commercial stack should still be treated as:
  - `20260501T162705Z_1084557944` = only candidate canonical path, but blocked by review/delivery contradiction and mixed lab-state flags
  - `20260427T173913Z_1084557944` = archive candidate stale placeholder
  - `20260425T214914Z_1084557944` = evidence-conflicted premium branch until readable labs are normalized
  - `20260425T212847Z_1084557944` = parked rewrite-only premium branch unless explicitly reactivated later

### Connector Delta
- Outward sync should now be treated as a two-layer system:
  - local sanitized artifacts must always be created
  - external connector writes count as successful only after a real call completes
- Current external state is:
  - Obsidian local mirror works
  - Notion write path is blocked by MCP startup timeout
  - GitHub write path is blocked by MCP startup timeout
  - Google Drive write path is blocked because upload/share tools are not exposed
- Strategy implication:
  - local sync remains mandatory
  - external replay remains queued, not completed

### Higher-Impact Replacement Action
- Run one truth-and-transport recovery sweep, in this order:
  1. add a hard guard so `delivered_to_client` cannot happen while review still requires revision unless an explicit manual override note is recorded
  2. normalize the governing `week` case so `lab_quality_check` and `requires_lab_resubmission` match the current follow-up truth
  3. classify the same-user stack into `canonical / archive / parked / evidence-only`
  4. replace the mini-app hardcoded result output and `2990` price drift with a safe placeholder aligned to Telegram-first reviewed truth
  5. prove whether polling can run cleanly without `127.0.0.1:12334`; if yes, prefer and document that path, and if no, treat proxy uptime as an explicit ops dependency
  6. restore Notion and GitHub connector startup health, expose Google Drive upload/share tools, and replay the pending outward-sync artifacts from `docs/external_sync/`

### Must-Hold Rules
- Keep Telegram as the only live operating channel.
- Keep manual concierge as the official pilot payment mode.
- Keep official pilot prices locked at `3900 / 6900 / 14900 RUB` unless a strategy doc explicitly changes them.
- Keep `week` as the validated paid entry rail.
- Keep `premium` as the flagship offer, but prove it from fresh post-`week` evidence rather than stale same-user branches.
- Keep exactly one canonical paid path per Telegram user.
- Keep human review mandatory before delivery.
- Keep no-diagnosis, no-treatment, urgent-care, and lab-quality rules explicit.
- Do not let the mini-app show hardcoded supplement protocols, hardcoded diet protocols, or off-policy pricing as if they were live truth.
- Do not treat `delivered_to_client` as trustworthy if the internal review verdict still demands revision and no override note exists.
- Do not treat a proxy-backed restart alone as proof of runtime resilience.
- Do not treat connector discovery as success if the first real write call times out during MCP startup.
- Do not let governance, docs, benchmarks, or UI polish outrun delivery truth, case-state coherence, transport proof, and connector recovery.

## 2026-05-05 21:30 MSK
### Artifact Delta
- Re-read the current source-of-truth artifacts before refreshing strategy:
  - `docs/PROJECT_PULSE_LOG.md`
  - `docs/KNOWLEDGE_SYNC_HUB.md`
  - `docs/AGENT_CONTEXT_HUB.md`
  - `docs/WELLNESS_DIALOGUE_QA_20260501.md`
  - `ops/reports/quality_report_20260501T080509Z.md`
  - `WellnessBot/data/runtime_state.json`
  - `WellnessBot/data/product_governance.json`
  - `WellnessBot/data/submissions/20260501T162705Z_1084557944.json`
  - `WellnessBot/data/drafts/20260501T162705Z_1084557944.review.json`
  - `mini-app/index.html`
  - `bot.stderr.log`
  - `docs/2026-05-04_nutrition-bot-architecture.md`
  - `docs/2026-05-05_STRATEGIC_MASTER_PLAN.md`
  - `docs/tasks/HERMES-20260505-*.md`
- New controlling evidence since the `2026-05-05 09:31 MSK` refresh:
  - `bot.stderr.log` now contains a clean startup on `2026-05-05 17:15:59 MSK`, active polling at `17:16:00 MSK`, and local HTTP hits through `17:59:23 MSK`
  - active local Python bot processes are visible again at `2026-05-05 21:30 MSK`, both started at `17:15:53 MSK`
  - the runtime is therefore no longer best described as `not currently evidenced as running`
  - but the active transport still explicitly uses `http://127.0.0.1:12334`, so proxy dependency remains unresolved and resilience is still unproven
  - the current canonical `week` case `20260501T162705Z_1084557944` now has fresh `2026-05-05` follow-up evidence:
    - PDF upload
    - two photo uploads
    - OCR correction prompt
    - user message `Ферритин 8мкг/л, референсы 10-20`
    - user message `Создай кейс`
  - the same case still simultaneously shows:
    - `intake_status = delivered_to_client`
    - `internal_review.judge_verdict = needs_revision`
    - no explicit manual override note
  - `mini-app/index.html` still shows off-policy `от 2 990 ₽` pricing and still hardcodes ferritin / vitamin D / cortisol conclusions plus `Витамин D3 5000 МЕ` and `LCHF` protocol output
  - governance pressure worsened relative to the morning sync:
    - `127` experiments
    - `4` duplicate title groups
    - largest duplicate group `x8`
  - execution-drift evidence also worsened:
    - `docs/tasks` now contains `29` `HERMES-20260505-*` task or draft files
    - several restate the same themes:
      - delivery gate
      - canonical client path
      - OCR fallback
      - premium copy
      - launch checklist

### Product Direction Delta
- Core direction still holds:
  - Telegram-first only
  - manual concierge payment remains the official pilot mode
  - `week` remains the validated paid entry rail
  - `premium` remains the flagship offer
  - `vip` remains parked
- The new correction is operational and wording-specific:
  - runtime should now be described as `up again but not yet proven resilient`
  - not `down`
  - and not `stable`
- The fresh follow-up uploads create a better premium-upgrade evidence base, but they do not justify a second active path or a new launch claim.
- Therefore the immediate product story tightens again to:
  - `Telegram-first clarity -> review-cleared week path -> fresh follow-up labs on the same canonical case -> one premium upgrade brief`
  - not `new parallel case creation from follow-up uploads`
  - not `task-packet swarm`
  - not `more architecture planning`

### Value Proposition Delta
- The clearest current value proposition remains:
  - `one Telegram thread that turns symptom chaos into a reviewed next-step map and then stays usable when new labs arrive`
- The trust gap is now more explicit:
  - the same delivered `week` case is already carrying new follow-up lab evidence while its internal review verdict still says `needs_revision`
  - the mini-app still shows autonomous-looking pseudo-medical output and off-policy price framing
  - the runtime is back up, but still visibly chained to a local proxy path that has not yet earned trust
- The next trust win is therefore:
  - repair delivery truth first
  - keep new follow-up evidence on the same canonical path
  - neutralize the mini-app result demo
  - prove the polling transport path with explicit verification

### Monetization Delta
- Official monetization posture remains unchanged:
  - `week` -> `3900 RUB`
  - `premium` -> `6900 RUB`
  - `vip` -> `14900 RUB`
  - payment mode stays manual concierge
- The monetization nuance is sharper than the morning sync:
  - the new ferritin correction plus uploaded follow-up files strengthen the evidence base for one `premium` upgrade brief
  - but that brief must stay blocked behind repair of the delivery-review contradiction on the same case
- No pricing, packaging, or payment expansion is justified by the latest evidence:
  - mini-app `от 2 990 ₽` remains off-policy
  - HERMES draft packets are not launch readiness
  - clean bot startup is not growth proof

### Operating Delta
- Runtime/storage truth remains good:
  - `WellnessBot/data/runtime_state.json` is still empty
- Runtime availability improved materially:
  - the bot is currently up again
  - polling is currently active
  - Python processes are visible
- But runtime resilience is still not proven:
  - the process still depends on `127.0.0.1:12334`
  - the current evidence set only proves clean startup and short local activity, not a proven stable path
- Active blocker order now sharpens to:
  - delivery-gate integrity on the current canonical `week` case
  - explicit rule that follow-up uploads must not spawn a second case
  - mini-app copy / price coherence
  - runtime transport proof with proxy-required vs proxy-optional clarity
  - governance compression and draft-swarm containment
  - one premium-upgrade brief from the fresh follow-up evidence

### Safety Delta
- Legal and safety posture remains unchanged:
  - no diagnosis framing
  - no treatment framing
  - urgent-care routing remains mandatory
  - human review remains mandatory before delivery
  - unreadable or unconfirmed labs cannot become product truth
- The new safety pressure is follow-up compounding:
  - new client-uploaded lab evidence is arriving on a case that still has unresolved internal-review defects
  - that raises the risk of building more client-facing motion on top of an already unsafe delivery state
- The surface safety regression remains unchanged:
  - the mini-app still contains hardcoded supplement-style and pseudo-medical result output

### Inefficiency Loop Delta
- Repeated low-impact loop:
  - generating more strategy packets, task drafts, and readiness docs while the same P0 code and surface defects stay open
- Repeated low-impact loop:
  - treating a clean same-day restart as if resilience were already proven
- Repeated low-impact loop:
  - using the same delivered `week` case as proof asset, follow-up intake bucket, and unresolved rewrite backlog simultaneously
- Repeated low-impact loop:
  - letting governance expand from `120` to `127` experiments while duplicate title pressure worsens from `x7` to `x8`
- Repeated low-impact loop:
  - discussing premium copy and launch readiness before delivery truth, mini-app truth, and polling-path proof are closed

### Higher-Impact Replacement Action
- Run one execution-compression sweep, in this order:
  1. keep `20260501T162705Z_1084557944` as the only active case candidate and record whether correction is required before more follow-up output is treated as usable proof
  2. enforce that the new `2026-05-05` follow-up uploads stay attached to the same canonical path and do not create a second commercial narrative
  3. remove the mini-app `от 2 990 ₽` price drift and hardcoded result demo
  4. verify whether the healthy polling path is proxy-required or proxy-optional, using the clean `2026-05-05` restart as the new baseline rather than as proof by itself
  5. freeze net-new strategy/task packet generation until at least one P0 delivery, surface, or runtime fix lands
  6. turn the fresh ferritin/lab follow-up evidence into exactly one premium-upgrade brief after the review contradiction is resolved

### Must-Hold Rules
- Keep Telegram as the only live operating channel.
- Keep manual concierge as the official pilot payment mode.
- Keep official pilot prices locked at `3900 / 6900 / 14900 RUB` unless a strategy doc explicitly changes them.
- Keep `week` as the validated paid entry rail.
- Keep `premium` as the flagship offer, but prove it from fresh post-`week` evidence rather than stale same-user branches.
- Keep exactly one canonical paid path per Telegram user.
- Keep all new follow-up uploads on the current canonical case unless an explicit replacement decision is recorded.
- Keep human review mandatory before delivery.
- Keep no-diagnosis, no-treatment, urgent-care, and lab-quality rules explicit.
- Do not let the mini-app show off-policy `от 2 990 ₽` pricing, hardcoded supplement protocols, hardcoded diet protocols, or hardcoded biomarker conclusions as if they were live truth.
- Do not treat `delivered_to_client` as trustworthy if the internal review verdict still demands revision and no override note exists.
- Do not treat the clean `2026-05-05 17:15 MSK` restart as proof that polling resilience is solved.
- Do not let governance, task-packet generation, or future-stack planning outrun delivery truth, surface truth, and runtime transport proof.

## 2026-05-05 09:31 MSK
### Artifact Delta
- Re-read the current source-of-truth artifacts before refreshing strategy:
  - `docs/PROJECT_PULSE_LOG.md`
  - `docs/KNOWLEDGE_SYNC_HUB.md`
  - `docs/AGENT_CONTEXT_HUB.md`
  - `docs/WELLNESS_DIALOGUE_QA_20260501.md`
  - `ops/reports/quality_report_20260501T080509Z.md`
  - `WellnessBot/data/runtime_state.json`
  - `WellnessBot/data/submissions/20260501T162705Z_1084557944.json`
  - `WellnessBot/data/drafts/20260501T162705Z_1084557944.review.json`
  - `WellnessBot/data/submissions/20260427T173913Z_1084557944.json`
  - `WellnessBot/data/submissions/20260425T212847Z_1084557944.json`
  - `WellnessBot/data/submissions/20260425T214914Z_1084557944.json`
  - `WellnessBot/data/product_governance.json`
  - `mini-app/index.html`
  - `landing/index.html`
  - `bot.stderr.log`
- New controlling evidence since the `2026-05-03 09:20 MSK` refresh:
  - no newer benchmark artifact exists than `ops/reports/quality_report_20260501T080509Z.md`
  - no new code, test, landing, or mini-app commits landed after `b6010bb`; live repo deltas remain documentation plus optional Docker dev artifacts
  - `WellnessBot/data/runtime_state.json` is still empty, so runtime/storage mismatch remains cleared
  - the delivered `week` case still shows `intake_status = delivered_to_client` while its attached review still says `needs_revision`, and there is still no explicit override note
  - the same user still also carries:
    - stale `week` placeholder `20260427T173913Z_1084557944` at `consent_pending`
    - paid `premium` branch `20260425T212847Z_1084557944` with `must_rewrite_with_high_caution`
    - paid `premium` branch `20260425T214914Z_1084557944` with `requires_lab_resubmission = true`
  - the mini-app still advertises off-policy `2990` pricing and still renders hardcoded ferritin / vitamin D claims plus supplement-dose and `LCHF` result output
  - governance pressure remains unchanged at `120` experiments, `4` duplicate title groups, and a largest duplicate group of `x7`
  - the latest runtime evidence is materially worse than the prior sync narrative:
    - `bot.stderr.log` ends at `2026-05-03 14:30:12 MSK`
    - the final visible outage window runs from `14:20:44` through `14:30:12 MSK`
    - that window includes repeated `ClientOSError [WinError 64]` and direct proxy refusals on `127.0.0.1:12334`
    - no active local Python bot process is visible at `2026-05-05 09:31 MSK`
  - disk headroom remains acceptable at approximately `18.97 GB` free on `C:`

### Product Direction Delta
- Core direction still holds:
  - Telegram-first only
  - manual concierge payment remains the official pilot mode
  - `week` remains the validated paid entry rail
  - `premium` remains the flagship offer
  - `vip` remains parked
- The sharper correction now is operational:
  - the next strategy win is not new packaging or new surface work
  - the next strategy win is restoring trustworthy delivery and a provable live operating path
- Therefore the immediate product story tightens to:
  - `Telegram-first clarity -> review-cleared delivery -> follow-up -> premium upgrade from fresh labs`
  - with a restored polling path that can actually sustain the pilot
  - not `mini-app proof`
  - not `stale premium proof`
  - not `docs moving ahead while runtime is down or unproven`

### Value Proposition Delta
- The clearest current value proposition remains:
  - `one Telegram thread that turns symptom chaos into a reviewed next-step map and follow-up`
- The trust gap is now more severe than the prior refresh:
  - reviewed truth is still weaker than delivery status because the current `week` case was delivered before review clearance
  - mini-app truth is still weaker than the backend safety posture because it shows hardcoded pseudo-medical output and off-policy price framing
  - runtime trust is weaker than operator intent because the latest evidence set ends in errors and no running bot process is currently visible
- The next trust win is therefore still operational:
  - clear the delivery-review contradiction
  - neutralize the unsafe mini-app surface
  - restore and verify a stable polling path instead of inferring one

### Monetization Delta
- Official monetization posture remains unchanged:
  - `week` -> `3900 RUB`
  - `premium` -> `6900 RUB`
  - `vip` -> `14900 RUB`
  - payment mode stays manual concierge
- No pricing or packaging expansion is justified by the latest evidence:
  - the mini-app `2990` display is still off-policy and must not be treated as a live offer
  - the delivered `week` case still validates demand, but not yet reusable hero proof because delivery outran review
  - a non-running or unverified bot runtime removes any basis for growth claims in the current window
- Near-term monetization path:
  - keep `week` as the validated paid entry
  - use the existing follow-up plus fresh labs to define one premium-upgrade brief
  - do not start new pricing tests, new offers, or new acquisition narratives before review truth and runtime availability are repaired

### Operating Delta
- Runtime/storage truth remains better than the April orphan blocker set:
  - runtime state is empty
  - disk headroom is above the safety floor
- But runtime availability has regressed relative to the last sync:
  - latest log evidence ends in repeated fetch failures and proxy refusals
  - no active local Python bot process is visible at the current sync time
- The active blocker order now sharpens to:
  - delivery-gate integrity
  - restore a verifiable running polling path
  - canonical same-user path retirement
  - mini-app copy / price coherence
  - model-path discipline
  - one fresh premium-upgrade brief
- Current same-user commercial stack should still be treated as:
  - `20260501T162705Z_1084557944` = only candidate canonical path, but blocked by review/delivery contradiction
  - `20260427T173913Z_1084557944` = archive candidate stale placeholder
  - `20260425T214914Z_1084557944` = evidence-only premium branch until readable labs exist
  - `20260425T212847Z_1084557944` = parked rewrite-only premium branch unless explicitly reactivated later

### Safety Delta
- Legal and safety posture remains unchanged:
  - no diagnosis framing
  - no treatment framing
  - urgent-care routing remains mandatory
  - human review remains mandatory before delivery
  - unreadable or unconfirmed labs cannot become product truth
- The active regressions remain:
  - delivered-state truth still outruns internal review truth
  - mini-app demo still contains hardcoded supplement instructions and disease-adjacent biomarker claims
  - runtime is no longer just unstable; it is not currently evidenced as up
- This keeps the main safety job unchanged:
  - protect what can be shown or sent as if it were reviewed truth
  - protect Telegram operations from silent transport fragility and silent downtime

### Inefficiency Loop Delta
- Repeated low-impact loop:
  - doc refreshes and status motion without code or operator changes that close delivery truth or restore runtime availability
- Repeated low-impact loop:
  - treating a stale error tail as if runtime were still implicitly up
- Repeated low-impact loop:
  - discussing stale premium branches instead of explicitly retiring them into `archive / parked / evidence-only`
- Repeated low-impact loop:
  - benchmark and tone work before delivery truth, runtime availability, and mini-app truth are repaired
- Repeated low-impact loop:
  - governance accumulation while `120` experiments and `4` duplicate title groups already exist

### Higher-Impact Replacement Action
- Run one truth-and-runtime recovery sweep, in this order:
  1. add a hard guard so `delivered_to_client` cannot happen while review still requires revision unless an explicit manual override note is recorded
  2. restore a running polling process and prove whether the stable path can operate without `127.0.0.1:12334`; if yes, prefer and document that path, and if no, treat proxy uptime as an explicit ops dependency
  3. classify the same-user stack into `canonical / archive / parked / evidence-only` and stop all ambiguity around the stale `week` branch plus the two older `premium` branches
  4. replace the mini-app hardcoded result output and `2990` price drift with a safe placeholder aligned to Telegram-first reviewed truth
  5. define exactly one premium-upgrade brief from the delivered `week` follow-up plus fresh labs, while freezing every other experiment

### Must-Hold Rules
- Keep Telegram as the only live operating channel.
- Keep manual concierge as the official pilot payment mode.
- Keep official pilot prices locked at `3900 / 6900 / 14900 RUB` unless a strategy doc explicitly changes them.
- Keep `week` as the validated paid entry rail.
- Keep `premium` as the flagship offer, but prove it from fresh post-`week` evidence rather than stale same-user branches.
- Keep exactly one canonical paid path per Telegram user.
- Keep human review mandatory before delivery.
- Keep no-diagnosis, no-treatment, urgent-care, and lab-quality rules explicit.
- Do not let the mini-app show hardcoded supplement protocols, hardcoded diet protocols, or off-policy pricing as if they were live truth.
- Do not treat `delivered_to_client` as trustworthy if the internal review verdict still demands revision and no override note exists.
- Do not call the runtime healthy while the latest evidence ends in fetch/proxy failures and no running process is visible.
- Do not let governance, docs, benchmarks, or UI polish outrun delivery truth, runtime availability, and Telegram operational resilience.

## 2026-05-05 09:30 MSK
### Artifact Delta
- Re-read the current source-of-truth artifacts before refreshing strategy:
  - `docs/PROJECT_PULSE_LOG.md`
  - `docs/AGENT_CONTEXT_HUB.md`
  - `docs/WELLNESS_DIALOGUE_QA_20260501.md`
  - `ops/reports/quality_report_20260501T080509Z.md`
  - `WellnessBot/data/runtime_state.json`
  - `WellnessBot/data/product_governance.json`
  - `bot.stderr.log`
  - `docs/2026-05-04_nutrition-bot-architecture.md`
  - `docs/2026-05-04_nutrition-bot-context-document.md`
  - `docs/2026-05-05_STRATEGIC_MASTER_PLAN.md`
- New controlling evidence since the `2026-05-03 09:20 MSK` refresh:
  - no new paid delivery proof, benchmark rerun, mini-app correction, or verified defect-closing code artifact exists for the live Telegram pilot
  - `WellnessBot/data/runtime_state.json` is still empty, so runtime/storage mismatch remains cleared
  - disk headroom is still safe but lower again at approximately `18.97 GB` free on `C:` as measured at `2026-05-05 09:30 MSK`
  - governance pressure is still unchanged at `120` experiments, `4` duplicate title groups, and a largest duplicate group of `x7`
  - `bot.stderr.log` now shows a newer recovered outage window on `2026-05-03 14:20:44-14:30:12 MSK` with repeated `WinError 64` plus explicit proxy refusal on `127.0.0.1:12334`
  - this newer `2026-05-03` window means runtime resilience is still not proven and the proxy path remains a live dependency question
  - the repo now contains new May strategy/reference artifacts that propose:
    - `nutrition_bot` as a separate architecture lane
    - Telegram/YooKassa automated payments
    - PostgreSQL, Docker, and admin/WebApp expansion
    - broader service catalog and more autonomous AI analysis framing
  - those artifacts are useful as reference material, but they are not aligned with current live-pilot truth:
    - official pilot payment mode is still manual concierge
    - official pilot prices are still `3900 / 6900 / 14900 RUB`
    - human review is still mandatory before delivery
    - Telegram-first still means one live operating path, not a second product stack

### Product Direction Delta
- Core direction still holds:
  - Telegram-first only
  - manual concierge payment remains the official pilot mode
  - `week` remains the validated paid entry rail
  - `premium` remains the flagship offer
  - `vip` remains parked
- The new correction is about roadmap containment:
  - the May `nutrition_bot` and strategic-master-plan docs are reference inputs, not the active execution plan
  - the live product remains `WellnessBot` proving one reviewed Telegram paid cycle
  - the next strategy win is still operational truth, not a second architecture, not payment automation, and not admin/TMA expansion
- Therefore the immediate product story tightens to:
  - `Telegram-first clarity -> review-cleared week delivery -> same-thread follow-up -> premium upgrade from fresh evidence`
  - not `parallel nutrition_bot build`
  - not `Telegram Payments rollout`
  - not `WebApp/admin scale-up before pilot truth is stable`

### Value Proposition Delta
- The clearest current value proposition remains:
  - `one Telegram thread that turns symptom chaos into a reviewed next-step map and follow-up`
- The new trust risk is roadmap drift:
  - the latest May docs lean toward `AI nutrition store + automated analysis` language that outruns the current reviewed service reality
  - this weakens the product promise if it leaks into live copy, pricing, or operator behavior
- The next trust win is therefore still:
  - delivery truth that matches review truth
  - one canonical same-user path
  - one safe Telegram-adjacent surface
  - one explicit statement that future AI/infra ideas are backlog, not live truth

### Monetization Delta
- Official monetization posture remains unchanged:
  - `week` -> `3900 RUB`
  - `premium` -> `6900 RUB`
  - `vip` -> `14900 RUB`
  - payment mode stays manual concierge
- The May architecture/context artifacts introduce off-strategy monetization drift:
  - alternate price points such as `2500 / 5000 / 15000 RUB`
  - Telegram/YooKassa direct-payment assumptions
  - broader service-catalog framing before one canonical proof path is stable
- These must stay backlog-only for now:
  - no pricing change is justified by the latest evidence
  - no payment-mode migration is justified by the latest evidence
  - near-term monetization is still `week -> reviewed follow-up -> one premium upgrade brief from fresh labs`

### Operating Delta
- The active blocker order sharpens to:
  - delivery-gate integrity
  - canonical same-user path retirement
  - mini-app copy / price coherence
  - runtime resilience with proven proxy or no-proxy behavior
  - live-model discipline
  - parallel-architecture containment
  - one fresh premium-upgrade brief
- New May infra and architecture drafts should be treated as:
  - reference-only until the live pilot truth gaps are closed
  - harvestable only for bounded assets such as prompts, OCR ideas, and service boundaries
  - not a justification for a second repo path, payment migration, or infra migration on the critical path

### Safety Delta
- Legal and safety posture remains unchanged:
  - no diagnosis framing
  - no treatment framing
  - urgent-care routing remains mandatory
  - human review remains mandatory before delivery
  - unreadable or unconfirmed labs cannot become product truth
- The new safety regression is planning-contamination risk:
  - alternate strategy docs can leak off-policy pricing, auto-payment assumptions, and more autonomous AI-result framing into live work
  - that is now part of the safety perimeter because current live operations are still human-reviewed and manually paid
- This keeps the safety job explicit:
  - protect what can be shown or sold as if it were live truth
  - protect the repo from roadmap drift that weakens current legal and operator discipline

### Inefficiency Loop Delta
- Repeated low-impact loop:
  - writing new master plans, Docker shells, and second-project architecture docs before closing delivery truth and runtime truth
- Repeated low-impact loop:
  - debating payment automation and admin/WebApp expansion before the current Telegram-first paid path is canonical and review-safe
- Repeated low-impact loop:
  - documentation motion that describes future AI autonomy while the live product still requires manual review and manual payment
- Repeated low-impact loop:
  - experiment accumulation while `120` governance items and `4` duplicate title groups already exist

### Higher-Impact Replacement Action
- Run one P0 truth-and-containment sweep, in this order:
  1. add a hard guard so `delivered_to_client` cannot happen while review still requires revision unless an explicit manual override note is recorded
  2. classify the same-user stack into `canonical / archive / parked / evidence-only`
  3. replace the mini-app hardcoded result output and off-policy pricing with a safe placeholder aligned to Telegram-first reviewed truth
  4. prove whether polling actually can run without `127.0.0.1:12334`; if yes, prefer and document that path, and if no, treat proxy uptime as an explicit ops dependency
  5. classify the `2026-05-04` and `2026-05-05` nutrition/master-plan artifacts as reference-only and extract at most one bounded asset package from them:
     - prompts
     - OCR approach
     - service-boundary ideas
  6. define exactly one premium-upgrade brief from the delivered `week` follow-up plus fresh labs, while freezing every other experiment

### Must-Hold Rules
- Keep Telegram as the only live operating channel.
- Keep manual concierge as the official pilot payment mode.
- Keep official pilot prices locked at `3900 / 6900 / 14900 RUB` unless a strategy doc explicitly changes them.
- Keep `week` as the validated paid entry rail.
- Keep `premium` as the flagship offer, but prove it from fresh post-`week` evidence rather than stale same-user branches.
- Keep exactly one canonical paid path per Telegram user.
- Keep human review mandatory before delivery.
- Keep no-diagnosis, no-treatment, urgent-care, and lab-quality rules explicit.
- Do not let the mini-app show hardcoded supplement protocols, hardcoded diet protocols, or off-policy pricing as if they were live truth.
- Do not treat `delivered_to_client` as trustworthy if the internal review verdict still demands revision and no override note exists.
- Do not call runtime stable just because polling eventually reconnects; the `2026-05-03 14:20:44-14:30:12 MSK` failure window still counts as an active ops issue until the path is proven.
- Do not let `docs/2026-05-04_nutrition-bot-architecture.md`, `docs/2026-05-04_nutrition-bot-context-document.md`, or `docs/2026-05-05_STRATEGIC_MASTER_PLAN.md` redefine the live roadmap.
- Do not move Telegram Payments/YooKassa automation, PostgreSQL migration, Dockerized infra, or a new admin/WebApp surface onto the critical path before delivery truth, canonical path truth, mini-app truth, and polling resilience are repaired.
- Do not describe automated AI analysis or delivery as live product truth while human review remains mandatory.
- Do not let governance, docs, benchmarks, or future-stack planning outrun delivery truth, canonical path control, and Telegram runtime resilience.

## 2026-05-03 09:20 MSK
### Artifact Delta
- Re-read the current source-of-truth artifacts before refreshing strategy:
  - `docs/PROJECT_PULSE_LOG.md`
  - `docs/KNOWLEDGE_SYNC_HUB.md`
  - `docs/AGENT_CONTEXT_HUB.md`
  - `docs/WELLNESS_DIALOGUE_QA_20260501.md`
  - `ops/reports/quality_report_20260501T080509Z.md`
  - `WellnessBot/data/runtime_state.json`
  - `WellnessBot/data/submissions/20260501T162705Z_1084557944.json`
  - `WellnessBot/data/drafts/20260501T162705Z_1084557944.review.json`
  - `WellnessBot/data/submissions/20260427T173913Z_1084557944.json`
  - `WellnessBot/data/submissions/20260425T212847Z_1084557944.json`
  - `WellnessBot/data/submissions/20260425T214914Z_1084557944.json`
  - `WellnessBot/data/product_governance.json`
  - `mini-app/index.html`
  - `bot.stderr.log`
- New controlling evidence since the `2026-05-02 21:19 MSK` refresh:
  - no newer benchmark artifact exists than `ops/reports/quality_report_20260501T080509Z.md`
  - no new code, test, landing, or mini-app changes landed since the last refresh; live repo deltas remain documentation-only
  - `WellnessBot/data/runtime_state.json` is still empty, so runtime/storage mismatch remains cleared
  - the delivered `week` case still shows `intake_status = delivered_to_client` while its attached review still says `needs_revision`, and there is still no explicit override note
  - the same user still also carries:
    - stale `week` placeholder `20260427T173913Z_1084557944` at `consent_pending`
    - paid `premium` branch `20260425T212847Z_1084557944` with `must_rewrite_with_high_caution`
    - paid `premium` branch `20260425T214914Z_1084557944` with `requires_lab_resubmission = true`
  - the mini-app still advertises off-policy `2990` pricing and still renders hardcoded ferritin / vitamin D / cortisol claims plus supplement-dose and `LCHF` protocol output
  - governance pressure remains unchanged at `120` experiments, `4` duplicate title groups, and a largest duplicate group of `x7`
  - bot polling showed a third same-day recovered instability window on `2026-05-02 21:38:36-21:38:48 MSK` with `ServerDisconnectedError`
  - this third window means the earlier fallback improvement claim is not yet enough to call runtime resilience solved
  - disk headroom remains healthy at approximately `22.97 GB` free on `C:` as measured at `2026-05-03 09:20 MSK`

### Product Direction Delta
- Core direction still holds:
  - Telegram-first only
  - manual concierge payment remains the official pilot mode
  - `week` remains the validated paid entry rail
  - `premium` remains the flagship offer
  - `vip` remains parked
- The stronger correction now is executional:
  - the next strategy win is not new packaging or new surface work
  - the next strategy win is making the existing paid path review-safe, singular, and operationally reliable
- Therefore the immediate product story tightens to:
  - `Telegram-first clarity -> review-cleared delivery -> follow-up -> premium upgrade from fresh labs`
  - not `mini-app proof`
  - not `stale premium proof`
  - not `ops recovery as a substitute for runtime stability`

### Value Proposition Delta
- The clearest current value proposition remains:
  - `one Telegram thread that turns symptom chaos into a reviewed next-step map and follow-up`
- The trust gap is now more specific:
  - reviewed truth is still weaker than delivery status because the current `week` case was delivered before review clearance
  - mini-app truth is still weaker than the backend safety posture because it shows hardcoded pseudo-medical output and off-policy price framing
  - runtime trust is still weaker than operator intuition because repeated reconnects happened after the prior fallback improvement
- The next trust win is therefore still operational:
  - clear the delivery-review contradiction
  - neutralize the unsafe mini-app surface
  - prove a stable polling path instead of inferring one

### Monetization Delta
- Official monetization posture remains unchanged:
  - `week` -> `3900 RUB`
  - `premium` -> `6900 RUB`
  - `vip` -> `14900 RUB`
  - payment mode stays manual concierge
- No packaging or pricing expansion is justified by the latest evidence:
  - the mini-app `2990` display is still off-policy and must not be treated as a live offer
  - the delivered `week` case still validates demand, but not yet reusable hero proof because delivery outran review
- Near-term monetization path:
  - keep `week` as the validated paid entry
  - use the existing follow-up plus fresh labs to define one premium-upgrade brief
  - do not start new pricing tests, new offers, or new acquisition narratives before review truth and runtime resilience are repaired

### Operating Delta
- Runtime/storage truth remains materially better than the April blocker set:
  - runtime state is empty
  - disk headroom is healthy
  - the old orphan runtime blocker remains cleared
- The active blocker order sharpens to:
  - delivery-gate integrity
  - canonical same-user path retirement
  - mini-app copy / price coherence
  - runtime resilience with proven fallback behavior
  - model-path discipline
  - one fresh premium-upgrade brief
- Current same-user commercial stack should still be treated as:
  - `20260501T162705Z_1084557944` = only candidate canonical path, but blocked by review/delivery contradiction
  - `20260427T173913Z_1084557944` = archive candidate stale placeholder
  - `20260425T214914Z_1084557944` = evidence-only premium branch until readable labs exist
  - `20260425T212847Z_1084557944` = parked rewrite-only premium branch unless explicitly reactivated later

### Safety Delta
- Legal and safety posture remains unchanged:
  - no diagnosis framing
  - no treatment framing
  - urgent-care routing remains mandatory
  - human review remains mandatory before delivery
  - unreadable or unconfirmed labs cannot become product truth
- The active regressions remain:
  - delivered-state truth still outruns internal review truth
  - mini-app demo still contains hardcoded supplement instructions and disease-adjacent biomarker claims
  - runtime is still described by recoveries rather than by a proven stable transport path
- This keeps the main safety job unchanged:
  - protect what can be shown or sent as if it were reviewed truth
  - protect Telegram operations from silent transport fragility

### Inefficiency Loop Delta
- Repeated low-impact loop:
  - doc refreshes and status motion without code or operator changes that close delivery truth or branch ownership
- Repeated low-impact loop:
  - treating a partial proxy-fallback improvement as closure even after a third same-day polling failure window
- Repeated low-impact loop:
  - discussing stale premium branches instead of explicitly retiring them into `archive / parked / evidence-only`
- Repeated low-impact loop:
  - benchmark and tone work before delivery truth, mini-app truth, and transport resilience are repaired
- Repeated low-impact loop:
  - governance accumulation while `120` experiments and `4` duplicate title groups already exist

### Higher-Impact Replacement Action
- Run one P0 truth-and-transport sweep, in this order:
  1. add a hard guard so `delivered_to_client` cannot happen while review still requires revision unless an explicit manual override note is recorded
  2. classify the same-user stack into `canonical / archive / parked / evidence-only` and stop all ambiguity around the stale `week` branch plus the two older `premium` branches
  3. replace the mini-app hardcoded result output and `2990` price drift with a safe placeholder aligned to Telegram-first reviewed truth
  4. prove whether polling actually can run without `127.0.0.1:12334`; if yes, prefer and document that path, and if no, treat proxy uptime as an explicit ops dependency
  5. define exactly one premium-upgrade brief from the delivered `week` follow-up plus fresh labs, while freezing every other experiment

### Must-Hold Rules
- Keep Telegram as the only live operating channel.
- Keep manual concierge as the official pilot payment mode.
- Keep official pilot prices locked at `3900 / 6900 / 14900 RUB` unless a strategy doc explicitly changes them.
- Keep `week` as the validated paid entry rail.
- Keep `premium` as the flagship offer, but prove it from fresh post-`week` evidence rather than stale same-user branches.
- Keep exactly one canonical paid path per Telegram user.
- Keep human review mandatory before delivery.
- Keep no-diagnosis, no-treatment, urgent-care, and lab-quality rules explicit.
- Do not let the mini-app show hardcoded supplement protocols, hardcoded diet protocols, or off-policy pricing as if they were live truth.
- Do not treat `delivered_to_client` as trustworthy if the internal review verdict still demands revision and no override note exists.
- Do not call runtime stable just because polling eventually reconnects; repeated same-day recovery windows still count as an active ops issue until the path is proven.
- Do not let governance, docs, benchmarks, or UI polish outrun delivery truth, canonical path control, and Telegram runtime resilience.

## 2026-05-02 21:19 MSK
### Artifact Delta
- Re-read the current source-of-truth artifacts before refreshing strategy:
  - `docs/PROJECT_PULSE_LOG.md`
  - `docs/KNOWLEDGE_SYNC_HUB.md`
  - `docs/AGENT_CONTEXT_HUB.md`
  - `docs/WELLNESS_DIALOGUE_QA_20260501.md`
  - `ops/reports/quality_report_20260501T080509Z.md`
  - `WellnessBot/data/runtime_state.json`
  - `WellnessBot/data/submissions/20260501T162705Z_1084557944.json`
  - `WellnessBot/data/drafts/20260501T162705Z_1084557944.review.json`
  - `WellnessBot/data/submissions/20260427T173913Z_1084557944.json`
  - `WellnessBot/data/submissions/20260425T212847Z_1084557944.json`
  - `WellnessBot/data/submissions/20260425T214914Z_1084557944.json`
  - `WellnessBot/data/product_governance.json`
  - `mini-app/index.html`
  - `bot.stderr.log`
- New controlling evidence since the 2026-05-02 09:19 MSK refresh:
  - no newer benchmark artifact exists than `ops/reports/quality_report_20260501T080509Z.md`
  - `WellnessBot/data/runtime_state.json` is still empty, so runtime/storage mismatch remains cleared
  - the delivered `week` case still shows `intake_status = delivered_to_client` while its attached review still says `needs_revision`
  - the same user still also carries:
    - stale `week` placeholder `20260427T173913Z_1084557944` at `consent_pending`
    - paid `premium` branch `20260425T212847Z_1084557944` with `must_rewrite_with_high_caution`
    - paid `premium` branch `20260425T214914Z_1084557944` with `requires_lab_resubmission = true`
  - the mini-app still advertises off-policy `2990` pricing and still renders hardcoded ferritin / vitamin D / cortisol claims plus supplement-dose and `LCHF` protocol output
  - governance pressure is unchanged at `120` experiments, `4` duplicate title groups, and a largest duplicate group of `x7`
  - bot polling suffered a second recovered same-day instability window on `2026-05-02 20:26:15-20:27:14 MSK` with `ServerDisconnectedError` and proxy refusal on `127.0.0.1:12334`
  - disk headroom remains healthy at approximately `23.45 GB` free on `C:` as measured at `2026-05-02 21:19 MSK`

### Product Direction Delta
- Core direction still holds:
  - Telegram-first only
  - manual concierge payment remains the official pilot mode
  - `week` remains the validated paid entry rail
  - `premium` remains the flagship offer
  - `vip` remains parked
- The sequence tightens further:
  - `week` is commercially validated
  - `week` is still not safe to use as the hero proof case until the review-versus-delivery contradiction is repaired
  - premium storytelling should come only after one canonical path, one review-safe delivery, and one stable follow-up path exist
- Therefore the immediate product story becomes:
  - `Telegram-first clarity -> reviewed delivery -> follow-up -> lab-backed premium upgrade`
  - not `mini-app result demo`
  - not `stale premium resurrection`
  - not `benchmark churn before product truth is fixed`

### Value Proposition Delta
- The clearest current value proposition remains:
  - `one Telegram thread that turns symptom chaos into a reviewed next-step map and follow-up`
- The trust gap is now even sharper:
  - delivery truth is still weaker than product promise because `delivered_to_client` can coexist with `needs_revision`
  - mini-app result content still claims more specificity than the reviewed backend can defend
  - repeated proxy recovery means operating continuity is not yet reliable enough to support broader surface claims
- The next trust win is therefore still operational:
  - make one delivered result review-safe and auditable
  - make the live-adjacent surface safe and price-coherent
  - make polling resilient enough that Telegram-first operations do not rely on a fragile local listener

### Monetization Delta
- Official monetization posture remains unchanged:
  - `week` -> `3900 RUB`
  - `premium` -> `6900 RUB`
  - `vip` -> `14900 RUB`
  - payment mode stays manual concierge
- No pricing or packaging expansion is justified by the latest evidence:
  - the mini-app `2990` display is still off-policy and must not be treated as a live offer
  - the delivered `week` case proves demand, but not yet a reusable premium proof story
- Near-term monetization path:
  - keep `week` as the validated paid entry
  - convert the current follow-up and fresh labs into one premium-upgrade brief
  - do not launch new pricing, new offers, or stale premium narratives before truth hardening lands

### Operating Delta
- Runtime/storage truth remains materially better than the April blocker set:
  - runtime state is empty
  - disk headroom is healthy
  - the old orphan runtime blocker remains cleared
- The active blocker order is now:
  - delivery-gate integrity
  - canonical same-user path retirement
  - mini-app copy / price coherence
  - polling resilience and proxy optionality
  - model-path discipline
  - one fresh premium-upgrade brief
- Current same-user commercial stack should now be treated as:
  - `20260501T162705Z_1084557944` = only candidate canonical path, but blocked by review/delivery contradiction
  - `20260427T173913Z_1084557944` = archive candidate stale placeholder
  - `20260425T214914Z_1084557944` = evidence-only premium branch until readable labs exist
  - `20260425T212847Z_1084557944` = parked rewrite-only premium branch unless explicitly reactivated later

### Safety Delta
- Legal and safety posture remains unchanged:
  - no diagnosis framing
  - no treatment framing
  - urgent-care routing remains mandatory
  - human review remains mandatory before delivery
  - unreadable or unconfirmed labs cannot become product truth
- The active regressions remain:
  - delivered-state truth still outruns internal review truth
  - mini-app demo still contains hardcoded supplement instructions and disease-adjacent biomarker claims
  - runtime is still exposed to a fragile proxy path without a documented fallback
- This means the main safety job is still:
  - protect what can be shown or sent as if it were reviewed truth
  - protect live operations from silent proxy dependency

### Inefficiency Loop Delta
- Repeated low-impact loop:
  - documentation and status motion that does not change delivery truth or branch ownership
- Repeated low-impact loop:
  - debating stale premium branches instead of classifying the four visible paths into canonical / evidence-only / parked / archive
- Repeated low-impact loop:
  - benchmark and tone work before the mini-app surface and delivery gate are repaired
- Repeated low-impact loop:
  - treating recovered proxy failures as solved simply because polling reconnected
- Repeated low-impact loop:
  - governance accumulation while `120` experiments and `4` duplicate title groups already exist

### Higher-Impact Replacement Action
- Run one truth-hardening and resilience sweep, in this order:
  1. add a hard guard so `delivered_to_client` cannot happen while review still requires revision unless an explicit manual override note is recorded
  2. classify the current same-user stack into `canonical / archive / parked / evidence-only` and stop all ambiguity around the stale `week` branch plus the two older `premium` branches
  3. replace the mini-app hardcoded result output and `2990` price drift with a safe placeholder aligned to Telegram-first reviewed truth
  4. verify whether polling truly requires `127.0.0.1:12334`; if not, document and prefer a no-proxy fallback, and if yes, treat proxy stability as an explicit ops dependency
  5. define exactly one premium-upgrade brief from the delivered `week` follow-up plus fresh labs, while freezing every other experiment

### Must-Hold Rules
- Keep Telegram as the only live operating channel.
- Keep manual concierge as the official pilot payment mode.
- Keep official pilot prices locked at `3900 / 6900 / 14900 RUB` unless a strategy doc explicitly changes them.
- Keep `week` as the validated paid entry rail.
- Keep `premium` as the flagship offer, but prove it from fresh post-`week` evidence rather than stale same-user branches.
- Keep exactly one canonical paid path per Telegram user.
- Keep human review mandatory before delivery.
- Keep no-diagnosis, no-treatment, urgent-care, and lab-quality rules explicit.
- Do not let the mini-app show hardcoded supplement protocols, hardcoded diet protocols, or off-policy pricing as if they were live truth.
- Do not treat `delivered_to_client` as trustworthy if the internal review verdict still demands revision and no override note exists.
- Do not call the runtime stable while polling still depends on an intermittently unavailable proxy path without a documented fallback.
- Do not let governance, docs, benchmarks, or UI polish outrun delivery truth, canonical path control, and Telegram runtime resilience.

## 2026-05-02 09:19 MSK
### Artifact Delta
- Re-read the current source-of-truth artifacts before refreshing strategy:
  - `docs/PROJECT_PULSE_LOG.md`
  - `docs/KNOWLEDGE_SYNC_HUB.md`
  - `docs/AGENT_CONTEXT_HUB.md`
  - `docs/WELLNESS_DIALOGUE_QA_20260501.md`
  - `ops/reports/quality_report_20260501T080509Z.md`
  - `WellnessBot/data/runtime_state.json`
  - `WellnessBot/data/submissions/20260501T162705Z_1084557944.json`
  - `WellnessBot/data/drafts/20260501T162705Z_1084557944.review.json`
  - `WellnessBot/data/submissions/20260425T212847Z_1084557944.json`
  - `WellnessBot/data/submissions/20260425T214914Z_1084557944.json`
  - `WellnessBot/data/product_governance.json`
  - `mini-app/index.html`
  - `bot.stderr.log`
- New controlling evidence since the 2026-05-01 evening refresh:
  - `C:` free space is healthy again at `23.01 GB` on `2026-05-02 09:19 MSK`
  - `WellnessBot/data/runtime_state.json` is still empty, so orphan runtime state is not the current blocker
  - the delivered `week` case still shows `intake_status = delivered_to_client` while its attached review still says `needs_revision`
  - the same user still also carries two unresolved paid `premium` branches:
    - `20260425T212847Z_1084557944` with `must_rewrite_with_high_caution`
    - `20260425T214914Z_1084557944` with `requires_lab_resubmission = true`
  - follow-up already started on the delivered `week` case (`"Я сдала анализы"`)
  - the mini-app still advertises `от 2 990 ₽` and still renders a hardcoded supplement / LCHF result demo that the reviewed Telegram backend cannot safely support
  - governance still contains `120` experiments, `4` duplicate title groups, and the largest duplicate group is still `x7`

### Product Direction Delta
- Core direction still holds:
  - Telegram-first only
  - manual concierge payment remains official pilot mode
  - `week` is now a validated paid entry rail
  - `premium` remains the flagship offer
  - `vip` remains parked
- The correction is about proof quality, not channel choice:
  - `week` is commercially validated because a paid case reached delivery and follow-up
  - `week` is not yet operationally trustworthy because delivery bypassed the internal review verdict
- Therefore the immediate product story becomes:
  - `Telegram-first clarity -> reviewed week result -> follow-up -> premium upgrade from fresh evidence`
  - not `stale premium resurrection`
  - not `mini-app autonomous dossier`
  - not `hardcoded medical-style protocol`

### Value Proposition Delta
- The strongest current value proposition is narrower and clearer:
  - `one Telegram thread that turns symptom chaos into a reviewed next-step map and follow-up`
- The new proof asset is not the mini-app mock result; it is the live delivered `week` path plus the follow-up signal.
- The trust gap is also clearer:
  - if delivery can happen while review still says `needs_revision`, the product promise is operationally weaker than the marketing promise
  - if the mini-app shows hardcoded supplement doses and LCHF output, the frontend is promising more medical specificity than the reviewed backend can defend
- So the next trust win is:
  - make one delivered result review-safe and auditable
  - then use that cleaned path as the base for one premium-upgrade narrative

### Monetization Delta
- Official monetization posture remains unchanged:
  - `week` -> `3900 RUB`
  - `premium` -> `6900 RUB`
  - `vip` -> `14900 RUB`
  - payment mode stays manual concierge
- New pricing-control delta:
  - `mini-app/index.html` currently shows `от 2 990 ₽`
  - this is out of alignment with the current pilot price truth and must not be treated as a live offer
- Near-term monetization path:
  - keep `week` as the validated paid entry
  - use the current follow-up plus fresh labs to decide whether the next paid move is a clean premium upgrade
  - do not use stale April premium branches as the flagship proof narrative

### Operating Delta
- Current runtime truth is materially better than the April blocker set:
  - runtime is up
  - runtime state is empty rather than conflicted
  - disk headroom is healthy
  - transient network issues recovered
- Current operating blocker order is now:
  - delivery-gate integrity
  - canonical same-user paid-path ownership
  - mini-app copy / price coherence
  - model-path discipline
  - one fresh premium-upgrade experiment
- Current same-user commercial stack:
  - `20260501T162705Z_1084557944` = delivered `week` case with follow-up, but review still says `needs_revision`
  - `20260425T212847Z_1084557944` = paid premium branch that remains rewrite-only
  - `20260425T214914Z_1084557944` = paid premium branch that remains evidence-only because unreadable labs still block it

### Safety Delta
- Legal and safety posture remains unchanged:
  - no diagnosis framing
  - no treatment framing
  - urgent-care routing remains mandatory
  - human review remains mandatory before delivery
  - unreadable or unconfirmed labs cannot become product truth
- The active safety regression is now surface drift:
  - the mini-app demo contains hardcoded supplement protocols and LCHF-style direction
  - the delivered-state pipeline can still outrun the internal review verdict
- This means the main safety task is no longer router reach; it is protecting what can be shown or sent as if it were reviewed truth

### Inefficiency Loop Delta
- Repeated low-impact loop:
  - carrying forward stale premium-branch debate instead of declaring the canonical path around the delivered `week` case
- Repeated low-impact loop:
  - polishing mini-app visuals while its price and hardcoded result content are strategically unsafe
- Repeated low-impact loop:
  - tuning model tone without first stopping review-gate bypass on delivery
- Repeated low-impact loop:
  - governance accumulation while `120` experiments and `4` duplicate title groups already exist
- Repeated low-impact loop:
  - documentation motion that does not harden delivery truth or collapse same-user sprawl

### Higher-Impact Replacement Action
- Run one truth-hardening cycle, in this order:
  1. add a hard guard so `delivered_to_client` cannot happen while internal review still requires revision unless an explicit manual override note is recorded
  2. review the delivered `week` case, decide whether client correction / follow-up repair is needed, and lock it as the canonical current path if it remains the active rail
  3. freeze or archive the two stale paid `premium` branches; keep `20260425T214914Z_1084557944` evidence-only and do not revive `20260425T212847Z_1084557944` unless there is an explicit post-`week` premium decision
  4. replace mini-app hardcoded result and `2990` price drift with a safe placeholder that matches the Telegram-first reviewed backend truth
  5. define exactly one premium-upgrade experiment from the fresh `week` follow-up and labs

### Must-Hold Rules
- Keep Telegram as the only live operating channel.
- Keep manual concierge as the official pilot payment mode.
- Keep official pilot prices locked at `3900 / 6900 / 14900 RUB` unless a strategy doc explicitly changes them.
- Keep `week` as the validated paid entry rail.
- Keep `premium` as the flagship offer, but prove it from fresh post-`week` evidence rather than stale same-user branches.
- Keep exactly one canonical paid path per Telegram user.
- Keep human review mandatory before delivery.
- Keep no-diagnosis, no-treatment, urgent-care, and lab-quality rules explicit.
- Do not let the mini-app show hardcoded supplement protocols, hardcoded diet protocols, or off-policy pricing as if they were live truth.
- Do not treat `delivered_to_client` as trustworthy if the internal review verdict still demands revision.
- Do not let governance, docs, or UI polish outrun delivery truth and canonical case ownership.

## 2026-05-01 09:17 MSK
### Artifact Delta
- Re-read the latest controlling artifacts before refreshing strategy:
  - `docs/PROJECT_PULSE_LOG.md`
  - `docs/PROJECT_NORTH_STAR_EXECUTION_PLAN_20260427.md`
  - `docs/PRODUCT_LINE_V2_20260426.md`
  - `docs/MANUAL_PAYMENT_MODE_20260426.md`
  - `docs/WELLNESS_DIALOGUE_QA_20260429.md`
  - `docs/GOOGLE_AI_STUDIO_MOY_PROJEKT_AUDIT_20260501.md`
  - `ops/reports/quality_report_20260429T080345Z.md`
  - `WellnessBot/texts.py`
  - `WellnessBot/data/runtime_state.json`
  - `WellnessBot/data/submissions/20260425T212847Z_<REDACTED_ID>.json`
  - `WellnessBot/data/submissions/20260425T214914Z_<REDACTED_ID>.json`
  - `WellnessBot/data/drafts/20260425T212847Z_<REDACTED_ID>.review.json`
  - `WellnessBot/data/drafts/20260425T214914Z_<REDACTED_ID>.review.json`
  - `WellnessBot/data/product_governance.json`
  - `docs/DISK_HYGIENE_STATUS.md`
  - `bot.stderr.log`
- New product-shaping evidence since the 2026-04-29 refresh:
  - `PRODUCT_EXAMPLES_TEXT` now gives a concrete safe demo fragment instead of generic promise copy
  - the Google AI Studio `moy-projekt` repo was audited and explicitly classified as UI/UX backlog, not backend truth
  - the bot is currently up after a clean restart on `2026-05-01 00:45 MSK`
- Core blockers did not improve:
  - `runtime_state.json` still contains runtime-only `week` session `20260427T173913Z_<REDACTED_ID>`
  - there is still no matching persisted submission JSON
  - the same user still also has two unresolved `premium` branches
  - benchmark truth still shows `20/20` routed and `0/20` model reached
  - governance memory still contains `115` experiments and `4` duplicate title groups
- A new operational emergency appeared during this run:
  - actual `C:` free space measured at `2026-05-01 09:17 MSK` is `2.69 GB`
  - this is materially worse than the last recorded `8.53 GB`
  - environment stability is now a first-order pilot blocker, not a background hygiene note

### Product Direction Delta
- Core direction does not change:
  - Telegram-first only
  - manual concierge payment remains the official pilot mode
  - `premium` remains the flagship proof path
  - `week` remains the lower-friction paid support rail
  - `vip` remains parked
- The new correction is about scope discipline:
  - the safer result example is useful because it closes a trust-gap in Telegram
  - the external React dashboard is not useful on the critical path because it creates a second product surface before one safe paid cycle is stable
- Therefore the next product story should be:
  - `safe Telegram intake + concrete example result + human-reviewed nutrition navigation`
  - not `AI dashboard`, not `new UI surface`, and not `personalized first-touch AI` until router overreach is cut

### Value Proposition Delta
- The validated value proposition remains:
  - `fact-safe nutrition navigation in Telegram with human review and same-thread follow-up`
- The trust proposition improved slightly:
  - the bot can now show a safer, more concrete demo of the output structure
  - this is the right kind of proof asset for the current stage because it explains the service without overclaiming
- The not-yet-proven layer is still explicit:
  - benchmark evidence still does not support a strong claim that first-touch chat is truly model-led or deeply personalized
  - deterministic templates are still doing most symptom-path work
- So the near-term value proof sequence is now:
  - keep the safe example result live
  - restore one coherent paid path
  - close one fact-safe reviewed cycle
  - then measure one genuine chat-quality improvement after router scope surgery

### Monetization Delta
- Monetization posture remains unchanged:
  - `week` -> `3900 RUB`
  - `premium` -> `6900 RUB`
  - `vip` -> `14900 RUB`
- The new demo example does not justify new pricing or a new package.
- The monetization question for the next cycle is narrower:
  - can the safer example result improve trust without pushing the team into new UI work?
  - can one coherent paid cycle actually close while the first-touch router is still being corrected?
- YooKassa / provider work remains off the immediate critical path while manual concierge mode works.

### Operating Delta
- The live same-user stack is still conflicted:
  - `20260427T173913Z_<REDACTED_ID>` = runtime-only `week` intake at `consent`
  - `20260425T214914Z_<REDACTED_ID>` = fresher `premium` evidence branch with `requires_lab_resubmission=true`
  - `20260425T212847Z_<REDACTED_ID>` = older `premium` rewrite candidate with review verdict `must_rewrite_with_high_caution`
- The live dialogue stack is still conflicted:
  - emergency and crisis routing remain useful and should stay deterministic
  - symptom and positioning prompts are still over-captured by templates
  - prompt/model tuning is still low leverage until routed share is reduced
- The live environment stack is now also conflicted:
  - runtime is up
  - but disk headroom is low enough to threaten continued artifact generation and safe operation
- Therefore the execution order changed:
  - environment survival
  - runtime/storage coherence
  - one active same-user path
  - router scope surgery
  - one safe paid proof path

### Safety Delta
- Legal and safety posture remains unchanged and must stay explicit:
  - no diagnosis framing
  - no treatment framing
  - urgent-care routing stays mandatory
  - unreadable or unconfirmed labs cannot become premium facts
  - human review remains mandatory before client delivery
- The new safety signal from the external UI audit is copy contamination risk:
  - the mock project contains overconfident medical-style language and pseudo-diagnostic wording
  - none of that wording should be copied into production
- The safe example result is only useful if it stays:
  - demo-only
  - non-diagnostic
  - based on clearly marked hypotheses and next-step clarification

### Inefficiency Loop Delta
- Repeated low-impact loop:
  - status-sync and documentation churn while runtime truth is still unresolved
- Repeated low-impact loop:
  - admiring or expanding the external dashboard mock while the Telegram pilot still lacks one coherent paid closure
- Repeated low-impact loop:
  - prompt or model tuning while `0/20` benchmark prompts reach the model
- Repeated low-impact loop:
  - governance growth while `115` experiments and `4` duplicate title groups already exist
- Repeated low-impact loop:
  - discussing packaging, landing, or UI expansion while `C:` is at `2.69 GB` free and the environment is near failure

### Higher-Impact Replacement Action
- Run one pilot-stability reset, in this order:
  1. restore `C:` above `10 GB` free using the manual delete-review queue, especially the large incomplete `.crdownload` files already identified in `docs/DISK_HYGIENE_STATUS.md`
  2. repair or clear `20260427T173913Z_<REDACTED_ID>` so runtime and storage agree
  3. declare exactly one active path for user `<REDACTED_ID>` and freeze the others
  4. shrink `route_live_reply()` so symptom prompts stop being fully template-owned
  5. keep the new example result text as the only conversion-surface improvement until one paid cycle closes

### Must-Hold Rules
- Keep Telegram as the only live operating channel.
- Keep manual concierge as the official pilot payment mode.
- Keep `premium` as the flagship proof path.
- Keep `week` as a support rail unless it is run on a clean separate user.
- Keep one active commercial path per Telegram user across runtime and persisted state.
- Keep human review mandatory before delivery.
- Keep no-diagnosis, no-treatment, urgent-care, and lab-quality rules explicit.
- Do not present router-template output as proof of personalized model performance.
- Do not merge the Google AI Studio dashboard into the current backend during this pilot cycle.
- Do not let docs, governance, launch chatter, or UI work outrun environment stability, runtime truth, and one coherent paid cycle.

## 2026-05-01 09:17 MSK
### Artifact Delta
- Re-read the current execution artifacts before refreshing strategy:
  - `docs/PROJECT_PULSE_LOG.md`
  - `docs/KNOWLEDGE_SYNC_HUB.md`
  - `docs/AGENT_CONTEXT_HUB.md`
  - `docs/GOOGLE_AI_STUDIO_MOY_PROJEKT_AUDIT_20260501.md`
  - `docs/WELLNESS_DIALOGUE_QA_20260429.md`
  - `ops/reports/quality_report_20260429T080345Z.md`
  - `WellnessBot/texts.py`
  - `WellnessBot/data/runtime_state.json`
  - `WellnessBot/data/submissions/20260425T212847Z_<REDACTED_ID>.json`
  - `WellnessBot/data/submissions/20260425T214914Z_<REDACTED_ID>.json`
  - `WellnessBot/data/drafts/20260425T212847Z_<REDACTED_ID>.review.json`
  - `WellnessBot/data/drafts/20260425T214914Z_<REDACTED_ID>.review.json`
  - `WellnessBot/data/product_governance.json`
  - `landing/index.html`
  - `mini-app/index.html`
  - `bot.stderr.log`
- New evidence since the 2026-04-29 refresh:
  - the Google AI Studio `moy-projekt` repo is a React/Vite UI mockup and must stay a UX reference, not a backend plan
  - `PRODUCT_EXAMPLES_TEXT` now shows a concrete safe demo-result fragment instead of a generic feature list
  - the bot restarted cleanly at `2026-05-01 00:45:55 MSK`
  - `C:` free space has fallen further to `2.69 GB`

### Product Direction Delta
- Core product direction does not change:
  - Telegram-first only
  - manual concierge payment remains the official pilot mode
  - human review remains mandatory before delivery
  - `premium` remains the flagship proof path
- The Google AI Studio repo should not redirect the roadmap:
  - use it as UI inspiration or future dashboard backlog only
  - do not treat it as an alternative operating backend
- The safer demo-result text is useful for trust-building, but it does not count as proof of delivery quality

### Operating Delta
- The state-truth conflicts remain unresolved:
  - `week_runtime_20260427T173913Z_<REDACTED_ID>` still exists only in runtime memory
  - the same user still holds two unresolved `premium` branches
  - `premium_fresh_20260425T214914Z` remains lab-gated and unsafe for delivery
  - `premium_legacy_20260425T212847Z` remains the only realistic rewrite candidate
- The live-chat blocker remains unchanged:
  - benchmark reference is still `ops/reports/quality_report_20260429T080345Z.md`
  - `20/20` prompts were routed before the model call
  - `0/20` prompts reached the model
- External contributor sync improved:
  - GitHub connector access exists for `olyalyazinchenk-wq/Zinchenko_wellness_al`
  - a missing local `git remote` is no longer a reason to skip GitHub status publication

### Plan Delta
- Move disk recovery ahead of any nonessential artifact generation or documentation churn:
  - the environment is now below `3 GB` free and can degrade mid-run
- Persist or clear `week_runtime_20260427T173913Z_<REDACTED_ID>` before carrying the paid-path story forward again
- Reduce the same-user paid stack to one active path before any delivery claim
- Shrink `route_live_reply()` before more prompt/model tuning so benchmark work can measure actual model behavior
- Keep the Google Drive access request unchanged until upload/create and share tools are exposed

### Strategy Delta
- The strategic bottleneck is now three-part, not one-part:
  - environment reliability
  - same-user state coherence
  - router overreach
- Therefore the next meaningful proof is no longer just a better dossier draft:
  - one stable workstation
  - one coherent paid path
  - one rerun benchmark where symptom prompts actually reach the model

### Goals Delta
- Goal 1: restore `C:` above the `10 GB` safety floor
- Goal 2: resolve the runtime-versus-storage mismatch and choose one active paid path
- Goal 3: narrow router scope and rerun the benchmark from a real model-reaching baseline
- Goal 4: keep the freshest premium branch frozen until readable labs or manual biomarker text clear the gate

### Next 12h Priorities
1. Free enough disk space to restore `C:` above `10 GB`.
2. Persist or clear `week_runtime_20260427T173913Z_<REDACTED_ID>`.
3. Declare one active paid path across the same-user `week` and `premium` stack.
4. Cut `route_live_reply()` back to safety/logistics coverage, add clarifying-question behavior, and rerun the benchmark.
5. Keep `premium_fresh_20260425T214914Z` frozen until readable labs or manual biomarker text arrive.

## 2026-05-01 21:18 MSK
### Artifact Delta
- Re-read the current execution artifacts before refreshing strategy:
  - `docs/PROJECT_PULSE_LOG.md`
  - `docs/KNOWLEDGE_SYNC_HUB.md`
  - `docs/AGENT_CONTEXT_HUB.md`
  - `docs/WELLNESS_DIALOGUE_QA_20260501.md`
  - `ops/reports/quality_report_20260501T080509Z.md`
  - `WellnessBot/data/runtime_state.json`
  - `WellnessBot/data/submissions/20260501T162705Z_1084557944.json`
  - `WellnessBot/data/drafts/20260501T162705Z_1084557944.review.json`
  - `WellnessBot/data/submissions/20260425T212847Z_1084557944.json`
  - `WellnessBot/data/submissions/20260425T214914Z_1084557944.json`
  - `mini-app/index.html`
  - `landing/index.html`
  - `bot.stderr.log`
- New evidence since the 2026-05-01 morning refresh:
  - `runtime_state.json` is now empty
  - a new `week` case has reached `delivered_to_client` and already has follow-up activity
  - the same user still also holds two unresolved `premium` branches
  - the latest QA truth moved to `ops/reports/quality_report_20260501T080509Z.md` with `11/20` deterministic replies and `9/20` model-path replies
  - the mini-app result screen still contains unsafe hardcoded diagnosis-like and supplement-style demo content

### Product Direction Delta
- Core product direction does not change:
  - Telegram-first only
  - manual concierge payment remains the official pilot mode
  - `premium` remains the flagship proof path
  - human review remains mandatory before delivery
- What changes is the current center of gravity:
  - the system is no longer blocked by router total capture
  - it is now blocked by delivery-gate integrity and conflicting paid-path truth for one user
- The mini-app should stay a supporting intake surface only:
  - it must not invent a polished medical-style result screen that outruns the reviewed backend product

### Operating Delta
- Runtime/storage coherence improved:
  - the old orphan `week` runtime mismatch is no longer the main blocker
- Delivery coherence worsened:
  - a `week` case has been delivered despite an unresolved internal review verdict
  - the same user now spans one delivered `week` path plus two unresolved `premium` branches
- Live quality improved but remains risky:
  - model reach is now real
  - false specificity, invented personalization, and tone discipline are now the main live-chat risks
- Surface safety remains uneven:
  - landing still matches the Telegram-first funnel
  - mini-app demo content still violates the intended safety and review posture

### Plan Delta
- Move delivery-gate enforcement ahead of further growth, packaging, or surface polish.
- Canonicalize the current same-user case stack before telling a stable commercial story.
- Replace unsafe mini-app demo content before relying on TMA as a live-adjacent proof surface.
- Keep GitHub and Notion artifacts fresh; keep the Google Drive access request unchanged until upload/create and share tools are exposed.

### Strategy Delta
- The main strategy correction is this:
  - restoring model reach was necessary
  - protecting what gets delivered is now more urgent
- The next proof target is therefore:
  - one review-safe delivered case
  - one canonical paid path per user
  - one safe intake/demo surface
  - one tighter model-path response style
- If those four items are not true, more growth or UI work just scales confusion.

### Goals Delta
- Goal 1: enforce a hard review gate before `delivered_to_client`.
- Goal 2: collapse the same-user `week`/`premium` sprawl into one canonical commercial path.
- Goal 3: remove unsafe hardcoded result content from the mini-app surface.
- Goal 4: harden model-path tone and specificity without losing the current `9/20` model reach baseline.

### Next 12h Priorities
1. Add a hard delivery guard so unresolved internal-review verdicts cannot be sent to the client without an explicit manual override record.
2. Decide the canonical path for the current same-user stack and freeze/archive the extra paid branches.
3. Review the delivered `week` case and determine whether a correction or follow-up intervention is required.
4. Replace the mini-app demo-result mock with a safe placeholder or reviewed backend-fed state.
5. Extend `sanitize_live_reply()` and benchmark assertions for invented names, over-familiar tone, and early diagnosis-like language.
